Exosomal miR-208a derived from the BMSC has been shown to negatively target programmed cell death protein 4 (PDCD4) in order to activate the ERK1/2 signaling pathway, thus promoting the proliferation, migration, and invasion of osteosarcoma cells [127]. This evidence concerns the gene MAPK3 and osteosarcoma.